首页
学术期刊
论文检测
AIGC检测
热点
更多
数据
RivaroxabanHaemorrhagic complications: 2 case reports
被引:0
|
作者
:
机构
:
来源
:
Reactions Weekly
|
2016年
/ 1589卷
/ 1期
关键词
:
D O I
:
10.1007/s40278-016-15033-7
中图分类号
:
学科分类号
:
摘要
:
引用
收藏
页码:180 / 180
相关论文
共 50 条
[21]
NatalizumabSevere haematological complications: 2 case reports
Reactions Weekly,
2013,
1433
(1)
: 33
-
33
[22]
Bleomycin/cisplatinNeurological complications: 2 case reports
Reactions Weekly,
2021,
1868
(1)
: 118
-
118
[23]
NatalizumabSevere haematological complications: 2 case reports
Reactions Weekly,
2010,
1327
(1)
: 28
-
28
[24]
RivaroxabanHaemorrhagic shock: case report
Reactions Weekly,
2023,
1970
(1)
: 249
-
249
[25]
Dabigatran-etexilateHaemorrhagic complications: 2 case reports
Reactions Weekly,
2016,
1583
(1)
: 379
-
379
[26]
BevacizumabHypertension and wound healing complications: 2 case reports
Reactions Weekly,
2019,
1748
(1)
: 85
-
85
[27]
ImmunotherapiesCentral nervous system complications: 2 case reports
Reactions Weekly,
2020,
1819
(1)
: 152
-
152
[28]
Ciclosporin/mycophenolate mofetilInfection complications: 2 case reports
Reactions Weekly,
2013,
1458
(1)
: 16
-
16
[29]
PlerixaforFatal pulmonary complications in children?: 2 case reports
Reactions Weekly,
2012,
1426
(1)
: 36
-
36
[30]
PyridoxineRebound effect and associated complications: 2 case reports
Reactions Weekly,
2019,
1778
(1)
: 402
-
402
←
1
2
3
4
5
→